Atogepant for the Prevention of Episodic Migraine in Adults: A Systematic Review and Meta-Analysis of Efficacy and Safety

INTRODUCTION: The inhibition of the calcitonin gene-related peptide (CGRP) pathway has attracted interest in pharmacological research on migraine. Atogepant is a potent, selective, orally available antagonist of the CGRP receptor approved as a preventive treatment of episodic migraine. This systemat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lattanzi, Simona, Trinka, Eugen, Altamura, Claudia, Del Giovane, Cinzia, Silvestrini, Mauro, Brigo, Francesco, Vernieri, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338214/
https://www.ncbi.nlm.nih.gov/pubmed/35705886
http://dx.doi.org/10.1007/s40120-022-00370-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338214/
https://www.ncbi.nlm.nih.gov/pubmed/35705886
http://dx.doi.org/10.1007/s40120-022-00370-8

Ejemplares similares